We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+7.36%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$657M
AUM Growth
+$275M
Cap. Flow
+$250M
Cap. Flow %
38.11%
Top 10 Hldgs %
46.95%
Holding
2,266
New
348
Increased
793
Reduced
382
Closed
125

Sector Composition

Rank Sector Weight
1 Financials 14%
2 Technology 12.89%
3 Consumer Discretionary 4.89%
4 Healthcare 4.71%
5 Communication Services 3.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMRX
2226
DELISTED
Chimerix, Inc.
CMRX
-14,395
Closed -$89K
ACCD
2227
DELISTED
Accolade Inc
ACCD
$0 ﹤0.01%
+12
New +$393
SYRS
2228
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
-51
Closed -$2K
BEST
2229
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
-243
Closed -$8K
AGR
2230
DELISTED
Avangrid, Inc.
AGR
-25
Closed -$1K
HIPO.WS
2231
DELISTED
Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share
HIPO.WS
$0 ﹤0.01%
450
TCON
2232
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
-100
Closed -$8K
HLTH
2233
DELISTED
Cue Health Inc. Common Stock
HLTH
-500
Closed -$6K
FPL
2234
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
-1,733
Closed -$10K
NGMS
2235
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
-218
Closed -$8K
CSTR
2236
DELISTED
CapStar Financial Holdings, Inc
CSTR
-102
Closed -$2K
ITCL
2237
DELISTED
Banco Itau Chile American Depositary Shares (each representing one third of one (1/3) Common Share)
ITCL
$0 ﹤0.01%
1
APRN
2238
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$0 ﹤0.01%
6
RAD
2239
DELISTED
Rite Aid Corporation
RAD
-111
Closed -$2K
RETA
2240
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-26
Closed -$3K
APPH
2241
DELISTED
AppHarvest, Inc. Common Stock
APPH
$0 ﹤0.01%
40
COUP
2242
DELISTED
Coupa Software Incorporated
COUP
-13
Closed -$3K
AERI
2243
DELISTED
Aerie Pharmaceuticals
AERI
-387
Closed -$4K
ZEAL
2244
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
-121
Closed -$4K
LOPX
2245
DELISTED
Direxion Low Priced Stock ETF
LOPX
-250
Closed -$2K
POLY
2246
DELISTED
Plantronics, Inc.
POLY
$0 ﹤0.01%
17
ATHX
2247
DELISTED
Athersys, Inc. Common Stock
ATHX
-27
Closed -$1K
ZNGA
2248
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
-717
Closed -$5K
TLMD
2249
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$0 ﹤0.01%
+315
New +$631
RVI
2250
DELISTED
Retail Value Inc. Common Shares
RVI
$0 ﹤0.01%
+2
New +$6

Similar funds

Lindbrook Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Lindbrook Capital held 2,266 positions worth $657M, up 72% from $382M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Lindbrook Capital deployed $250M of net new capital in Q4 2021, opening 348 new positions and adding to 793 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 192,700 shares worth $10.9M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Morningstar Total Stock Market ETF, an estimated $1.92M trimmed.

  • Lindbrook Capital's largest Q4 2021 buy was iShares Core S&P Mid-Cap ETF: 192,700 shares worth $10.9M.
  • Lindbrook Capital added most to iShares Russell 1000 Growth ETF in Q4 2021, an estimated $29.7M increase.
  • Lindbrook Capital's biggest Q4 2021 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $1.92M.
  • Lindbrook Capital fully exited iShares MSCI South Korea ETF in Q4 2021, selling an estimated $93K.
  • Lindbrook Capital's ten largest holdings make up 47% of its $657M portfolio in Q4 2021.
  • Lindbrook Capital opened 348 new positions and closed 125 in Q4 2021.
  • Lindbrook Capital's portfolio value rose 72% quarter-over-quarter to $657M.

Based on Lindbrook Capital's 13F filing for Q4 2021, filed 18 Jan 2022.